Clinical Trials in the UK / NCT07006090
Recruiting
Observational
EU Post-Market Registry to Collect Real-World Clinical Data on the Use of the Histolog Scanner.
NCT07006090 · tracked via the Priya Life Science UK tracker
Condition(s) studied
Adult Patients Undergoing a Surgery or a Medical Procedure With Use of Histolog® ScannerWhatever the Disease Area
Investigational drug(s) / intervention(s)
Histolog Scanner
Histolog Scanner: Histolog Scanner intended to allow imaging of the internal microstructure of tissues including, but not limited to, the identification of cells, vessels and their organization or architecture.
Study summary
The goal of this observational study is to gather real-world evidence on the performance and safety of the Histolog® Scanner (HLS) when used as intended. HLS is a real-time ex-vivo tissue imaging device.
Eligibility
Inclusion Criteria:
* Age ≥18 years old at the time of consenting
* Undergoing a surgery or a medical procedure with use of Histolog® Scanner
* Ability to understand and the willingness to sign a written informed consent.
Exclusion Criteria:
* Active participation in a drug, device, or other medical intervention study that has not reached its primary endpoint at the time of consenting
* Patients under judicial protection, legal guardianship or curatorship.
Primary outcome measure(s)
- Number of confirmed medical interventions based on Histolog® image readings. — From enrolment to diagnosis confirmation at post surgery follow-up visit (V2: 37 days after enrolment)
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Royal Surrey County Hospital NHS Foundation Trust | Guildford | United Kingdom | Recruiting |
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07006090 on ClinicalTrials.gov ↗ ← All trials in the UK